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p70 Ribosomal protein S6 kinase is a critical down-
stre am effector of a mitogen-stimulated signaling 
pathway that is selectively inhibited by the immuno-
suppressant rapalnycin. The purpose of this study was 
to quantify S6 kinase expression in psoriatic involved, 
uninvolved , and normal epidermis and to character-
ize regulation ofS6 kinase activity in cultured normal 
human keratinocytes. S6 kinase activity was in-
creased 4-fold in psoriatic lesions (1.63 ± 0.25 pmol 
per l11in per mg, 11. = 6), compared to nonlesional 
(0.44 ± 0.12 pmol per min per mg, n = 6, P < 0.01), 
a nd normal (0.35 ± 0.14 pmol per mill. per mg, n = 7, 
P < 0.01) epidermis. In contrast, S6 kinase mRNA and 
protein levels were not significantly different among 
psoriatic lesional, nonlesional, and normal epider-
mis . In keratinocytes, S6 kinase activity was stimu-
lated 3-fold by 111itogenic epidermal growth factor 
(EGF ) receptor ligands, EGF and transforming 
growth factor-a (TGF-a), but not by cytokines inter-
leukin-la, tUlnor necrosis factor-a, interferon-/" or 
transforming growth factor-/31. TGF-a stimulation 
S 6 kina se is a mitogen-activated sc rine/threonin c kina se tha t ph osph o rylates 40S ribosoma ,l pro te in S6, (rev iewed ill Ferrari e/ nl, 1993 ; ))ownwa nd , 1994) . p70S (')</ p8S S(')< arc 70-kDa and 8S-kDa fo rms ofS6 kinase deriv ed from a CO lll111 0 11 gcne by alte rlla t ive spli cing . p70s,')< / p8 Ss''', 
(hen ceforth re ferred to as SCI kinase) is acti v;1tcd by phosphorylation 
;I t Illul tipl e se rin e and threonin e res idu es ill respo ll se to l11itogens 
;lIl d lies o n a signalin g path way that is di still c t 0 '0111 tha t o f Ra s 
(p2 1 "") and mi togen-activated protein killase (p42/p44 "W I'K) (Bal-
lo u cI (I I. 199 '1; C hun g 1'1 al. '1992 ; Ferrari ('I (I I, I ~~3 ; Min g el al. 
I <)')4). Phosphoryla tio n of ribosom;ll protein S6 by S6 kinase may 
indu ce o r stabilize fi))l ctio nal confo rrnatio l1al chan ges in ribosom es 
that pre fe r 'n ti all y t rall slate a famil y o f Il1I~N As-en coclin g prote ins 
needed fo r C 'I progressio n (D owll w and , 1994; Stewart and 
T ho lll as . 1(94). Neu trali z ing antibodi es again st Sfl kina se inhibit 
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ofS6 kinase activity was inhibited in a concelltratioD_ 
dependent manner by rapamycin (ICso < 0.2 nM) and 
the specific EGF receptor antagonist PD153035 (ICso 
= 20 nM). Rapamycin also inhibited EGF-stimulated 
proliferation of keratinocytes (ICslI = 0.2 ng per tnl) 
with a potency similar to that reported for inhibition 
of T -cell proliferation. We conclude: (i) the l11ito~ 
genic signaling pathway(s) regulating S6 kinase is 
activated in psoriatic lesions, thus accounting for 
increased S6 kinase activity in the absence of in~ 
creased S6 kinase gene or protein expression; (ii) S6 
kinase activation in lesional keratinocytes likely oc~ 
curs in response to EGF receptor stimulation b y 
TGF-a and/or amphiregulin, which are known to be 
elev'Jted in psoriatic lesions; and (iii) keratinocyte as 
well as T-cell mitogenic signaling pathways are sus~ 
ceptible to inhibition by rapamycin, suggesting that 
rapamycin may be of therapeutic benefit in the treat~ 
ment of psoriasis. Key wOl'ds: psol'iasis/I'apalllydll/tm1ls_ 
IOI'II,illg gl'omtl' jactol'-a. ] Illvest Dermatol 108:98-102, 
1997 
serum- indu ced entry into S phase of the ce ll cycle in qu iescent rat 
embryo fIbroblasts (Lane cr (II . 1(93). T hese find ings suggest that S6 
kinase p lays an important ro le in ce ll prolife ration. 
R.apam ycin is a stru ctural analog of the macrolide immunosup_ 
pressa n t FKS06, ;lI1d. like FKS06, binding of rapamycin to FKS OG-
binding pro tein (FKBP) is required for its biologic ac tivit'" 
(Schri eber. 1992) . Unlike FKS06-FKl3P , howe ver. rapamycin', 
FKI3P does not inhibit calcinurin. Rather, rapam)'cin-FK]3P inhibits 
phosphoryl"tio n and ac tivatio n o f S6 kinase (C hung ct III, 1992; 
Pri ce " f (I I . 1992; Terada cf (/1, 1993) . Rapam )'cill is a pote n t 
inhibi to r o f T-cell pro liferati o n (Quesniaux , 1993; Schrei e r CI nl, 
1993; Tho mso n and Starz l, 1993), acting to inhibit progressio n 
throu gh th e C I phase of the ce ll cycle (l3eirer 1'1 (II. 1990; Dumo nt 
l'f al. 19( 0). T he immunosuppressive effects of rapamycin arc like ly 
associ;lted with its ab ili ty to inhibit activation of S6 ki na se. . 
The purpose of this study was to determine 'w heth er S6 kinase is 
activated in pso riatic lesions and to inves tigate ago nist <l c tivatio n 
and rapam ycin sensitivity o f S6 kinase activity in hum an keratino_ 
cytes. W e find chat 56 kinase act ivity. but not its mRNA or pro tein. 
is signifi cantly increased in pso riatic in vo lved e pidermis. and th at 
transfo rmin g gro wth fa cto r-a (TCF-c~) and epidermal growth 
f;, ctor (EG F). acting throu g h the EGF receptor, stimulate S6 kinase 
activit)' , w hich is inhibited by rapamycin. in human ke rati nocytes. 
These data suggest that S6 kinase activity in psoriati c lesions is 
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in c reased thro u g h activation of EGF recepto rs b y its li ga nds , w hi c h 
a re known to b e e levated in psoriati c les io n s (Elde r el nl. 1989; 
C ook c( nl. 1')92). a n d m ay be invo lved in the pathogen es is of 
psori atic e pide rmal h yperp las ia. 
MATER.l ALS AN I) METH ODS 
Reage nts P..abbit all rihody to p71J SC, killase and S(, kinase substrare 
pepti de we re purcha sed frolll Upstate Bintecilll o logy (Lake Plac id . NY). 
Recomhinanr human TGF-a. EGF. tliln o r lI ecrosi s f"ctor-tr (TNF-tr). 
t ransfo rming growth facto r- b t:ra I (TGF-{3 I) . illre rfe rOIl -y (IFN-y) . " lid 
intc r leu kin - I Ci (I L- I (I') wt:re purchased li'o m It &: J) Sys tems (M inlleapoli s. 
MN). H o rse rad ish peroxidast:-colljugated goat anti - rabbi t IgG an d Coo-
mass ie p lus p rorcin assay reagem wt:rc o btain ed fro nl Pit:rce C hemical Co . 
(Rockford , I L) . C hcnlilumincscenr ho rse radi sh pe roxidase substrat t: (ECL) 
was purchased frolll Am ershalll (A rlington H eights. IL). R cagem s fo r 
prote in si lver srainin g IVere li'om Uio-Rild La bo ratories (H e rc ule s. CAl . 
.l 2P_Labc led ra d io iso topes were purchased from DU POilt NEN ( \X1ilming-
ton , DE). Prote in A Sepharl'se :lIld ces iu l1l chlo rid e IVt: rc purchast:d li'om 
Pharm acia Biol'ee lt (Piscatawa y. NJ ). PS I phosl'hoce llulose paper was ii'o m 
Whatm an (Hill sborl' . OR) . Ny lo n Inel1lhrant: used fix Northern analysis 
and ni troce ll ull'se m ernbr:1Il e used for western bl ot we re o b ta ined fi'l' m 
Schle iche r &' Sc ltu e ll (Keene . N H ). ltand l' lll priming cDNA labe ling kit 
was from Pro m eg:1 (Madison . W I). Full- Ie llgdl eDNA fo r hlllll a ll S6 kill" se 
was k ind ly prl'v ided hy Dr. J. Av ru ch (Harva rd U ni vers ity. C ambridge. 
MA). Protein k inase A inhibitor was fro m Life Techno logies (Gaithershurg. 
MD). Unl ess othe rwise sta ted. a ll o ther chemica ls used we re o btai li ed li'o lll 
Sig m a (St. Lo ui s. MO). Itapa m yc in was kj ndl y prov id ed by W ye rh-A yerst 
Researc h Laboratories (Prin ceto n. NJ) . 
Tissu e Salnples Keratl' nlC bio psies from \1onna!. pSl'ri atic illvolved . and 
pso r iati c IInin vo lved (normal apP":1ri ng) epidermis IVere o b t:1 ined as de-
sc ri b ed prev ious ly (F isher ,.( ,II. 199 I). Kerato lll e blade d ep th was set at (l.~ 
ml11 for 1I 0 rll1al and pSl' ri atie ulli\1\'o lvcd skill and O.~ Inl1l fo r pSl' riati c 
in vo lved skin. rcs u lt1n g ill exc isio n 11 'a r rhe cp idcnna l-dc r111 a l jUllc tio n . 
Biopsies 'were illullcdiatcly s lI 'lp- frozc n ill li q uid Ili t rogen a n d sto red at 
- 70°C u n til used. All sub.i ects provided wrinell . illforll1ed consent. alld a ll 
procedu re s invo lv in g hllln an s Ll I~ j ccts were pcrfo rillcd und er approva l of tilL' 
U nive rsity o f Mic hi ga n M edica l Cen ter Insri tTl tlo l1:J1 I'l...cvic w l3oard. 
Kcratinocytc C ultures and T r catl11c Il ts I-I 11 111 an kcratinocY l' 'S were 
prepared fi'l' m ke rato lll e b il'Ps ies of I1 l' n na l ad ul t sk in as previl' usly 
described (S hipl ey all d Pi n e lkow. 1987: R eyno lds ('( nl. 1994). Ce ll s we re 
g ro\·vn as Inonola ycr cultures in sc rl1l11-fi·cc. low cal c illrn c0 l11 p lc-tc M e DU 
153 m ed iul11 (l' it te lkow and Scot t. 191)6). C ells were seeded in to Ill-em 
diam e ter plastic dishes at a de nsity of I X I U', ce lls per di sh alld incubated 
in a hurnidi ficd in c llb;l to r \v ith SIXI CO:! , 951X, ai r :1 1 37°C and treated w ith 
ago ni sts a l' 90':;', cO ll llucnee. Before t reatl11ents with ago ni sts (J 0 ng pe r ml ) . 
cell s were placed in growth fac lor-li'ee MCD B '153 lIl edi ul11 lo r 24 h . Cell s 
w cre treated with ago ni sts (TGF-cr. EGF. TNF-(\'. TGF-{:l l . IFN-y. and 
IL-lct) for ~ () m ill at J7"C. P .. al' ,"n ),c ill or 0.1 % ethano l \V.1S added ro ce lls 
10 min p ri o r to addition or ago n isl. 
Preparation of Cell-F ree Lysates C e ll -r-j'ee Iysates we re pn .:pared as 
desc ribed prev io usly (Terada ('( ,II. 1'i'i3). Brid ly. froze n ke ra tl' lnes wei'll 
ground under liquid Ilitrogen w ith l11 0 nar a lld pestl e and ho m l'geni zed in a 
g lass h o m oge lli zer 0 11 icc w ith ~ 1111 of lys is b ll iFer (p H 7 ... 1. I n 111M porass iull1 
phosp hate. I 111M ethylened iami ne tetraacetic acid. 5 111M e th ylene g l)'co l-
b is fJ3-:1l11i noeth yl e l'il e rJ -N . N.N ' .N'- te rraa ce ti c acid. 10 111 M M gC I2 • Sil 
mM f3- g lycerophosp hate . I 111M sod iul11 o rth ov:lI1 adate . 2 111M dithiot h re-
ito l. 40 J.Lg phenyll11eth ylsttll'o n yl Auo ride per 1111. 1), 5% Nonidet 1>-4U. :lI1 d 
1 oj" Triton X I (0). I-Io ll ioge ll ate s we re ce ll trilliged ar 11111.11110 X .~ tor I II at 
4 ° C, a n d supern ata n ts weft...' lI sed for kinase assay and inllllul1o hl ot: anal ysis. 
For c ul tured keratinocyres. ce ll s we re washed w ith co ld p hos pitate- bllife red 
sa line aJld we r e lysed :I n d li o llt o!;c llized ill a g la ss il o lllogcll izc r On ice \v itll 
1 ml o f lys is bulle r. Lysates were ce lltr irllged as above to obtai n hi gh speed 
supernatant. T he protein concc lltrat iol1 o f supernatants \·va s lncasnrcd usin~ 
a Cooll1 :lss ic p lu s prote in rca ~c llt w idl 1 Illln :lI I scrU l1l a lb lllll ill as st;ll1d ~lI·d . 
lmnlultoprecipitation and Kinase Assays IlI1Inli lloprec ipi t:1tiollS :1lld 
assays fo r S(, k.in ase activi ty \,vcrc pl!rfOrlll Cn as previo usly d escribe d (Terada 
e( ai, 1993). UrieH y. 100 f.l l o f ce ll -free lysate were ill cuba ted lo r 2 h n n icc 
w ith rabbit po lyclo llal an ti-p70 S6 kinase a l1 ti hody. In llnllllC complexes 
\vcrc rn ixed w ith Protei n A Scph arosc beads fo r 1 11 0 11 icc :lOci cen trifug ed 
a t 14 .0()() X .~ for 5 l11i n. T he reSti ltillg precipitates were w:1s hed a ll d 
su spen ded in 50 f.l l l'rk ill as\.!. assay huH"r [21l111M Tr is(h yd roxYlllethyl)all1i-
no metbane-H C I. pH 7.5 . IIIIllM M gClo, O. I m g bl'v ine seruln alhumill per 
m l, 0.4 mM dithio t lt re ito l. 2 J.LM prote in k ill ase A inhibi tor. 100 f.lM 
un hlbe led ATP. 20(1 !-LC i [y_.1 2p[ ATi' per 1111. 115 f.lM SC, ki ll ase substrate 
peptide J and t lt e ll inc ubated fo r 15 l1I in at .'10°C . Afte r a briefcelltri(lI garioll . 
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F igure L S6 kinase activ i ty is increased in psoriatic lesions. S6 
kinasc was a ss:ty~d ill inlllll l1l 0prcc ipitates of soluble fi'actio ns fronl ke ra-
tl'l1Ie bi l'Psies by phl'sp hnryl:1 rio n of ribosomal protein S6 sYl1 the tic peptide 
substrate . as desc ribed in ;Vln(l'ri"/, nlld JIIe(fro,/;-. Data arc m ea nS =: SEM 
o bt:1il1ed fro l1l six (u nil1 vo lved and ill vl' lved) l' r seven (no rll1a l) subj ects. 
*. p < 0.002: in vl' lved I'ers lls unin vl' lved: p < (l . O(J'l: invl' lved I'(' rs((s 
n Ortll a l . 
25 J.L I of the supernata nt were spotted o n W ltarnw il PS I plt l'sp ltoce llul osc 
pap e r and washed fin:! t illles w ith ! IXI p hospho ri c ac ici. R.ad ioactivity bound 
ro ,·i ltc rs \vas cOllnted w ith a liquid scinti ll ation spectro ln etcr. alld results 
We re ll o r111 a li zcd to p rotein con cen tff.lcio n. 
Northern Blot Analysis Tota l R N A was isolated fi'om keratome biop-
sies or 11 0 r111 :1 1. psoriatic in vo lved, and psoriati c unin vo lved skin by ccsiunl 
chlo ride gradienr ce ntri fll~atil' lI as desc ribed (Elder C( 07/. 1990b). Equa l 
amoulIl's (40 !-Lg per lane) of extracted tota l I,-NA w"rc size fj'anionated by 
elec trop ho res is n n 1.2%1 fo nll a lde h yde 'l ga rOSe gel s. IT;! Tl s fc rred (0 n ylo ll 
l1I e mhr:1Il c. all d probed with randoll1l), i:1bded S6 kin:t sL' e DNA . .'l(,B4 
eDNA probe was used as an inte rnal co n tro l for load ing (J6B4 encodes a 
ri ho som al pro te in ). H yhridi zati l' n s ignals we re detected and q U:lnljii ed hy a 
1I10del 4()UE Phosphorlmager (Molecu lar Dynamics . Sunn yva le , CAl· 
Western Blot Analysis S upc rn ;H:1ntS ti'o nl n o rmal. psoriati c invo lved . 
and pso ri :ltic unil1 \'o lvcd sk ill wcrc prepared as describ ed ab o ve, :l ll d equal 
<l 111 0 UlltS of proteins (40 p..g pCI' la ll e) wcre reso lved SIXI sodilllll dodecyl 
slIl1ilte-po lyac rylal1lide ge l e lectropho resis (Laemm li . 1'i70). Prote ins were 
transferred 1"0 uitroce llulosc l1l e lllbral1 es anel in cubated w ith antibody 
specific 1'0 ,,70 56 kinase <lnd secondary horse radish pcroxi(iasc-collju ga ted 
;llllibod y. 56 kina se/ alltibody cOlll plexcs were visua li zed b y e n h anced 
chel11i lllmillescence :1IId exposed to Kodak X-OM AT AI1.. film. Signal s 
detected 011 x- ra v fi llll wcre qll;}l1titied by laser dellsitolllcrry. Transterred 
prote in s we re s~a iJl cd with l 1X, ;]ll1id o b lark to l'o n firnl ullifof111iry of 
(ra nste r. II11111Ul1 e complexes prec ipi tated by Protein A Scp l1:1rose beads as 
d escribed above were reso lved b y ~IY. I sod iutl1 dodecy l su lf:Hc-po lyac ryl-
;ltllide ge l e lectroph ores is. ;lIld th e gels were di rcc ll y sil ve r sta ill c d . 
I{cratinocytc Gro \vth Assay Kerarill ()c)'tcs (5 X 10J per well ) werc 
plated il1t l" 9C,-we ll mi crotiter pla tes and a llowed tl' attach (or I tl h . 
Rapa\l1 yc in l' r 0. 1 % etha ll o l was added to the m edi ul11 . and ce ll s were 
a llowcn to prolifc r :Ht...' 5-7 d . c ll nllInbe r was as:\csscd b y ncutral red assay 
(Ua hich and Uore ll freu ll d . 1')1)7) . Eigh t wel ls were used fl'r each treatment 
alld their va ll1 cs :l vc r:l~ed, 
Statistical A n a lysis Di fFerences in activity. mRNA. and protein 1e"L' ls o r 
S6 kinase ill Il o nn;d . psor i ~l ti c iJl voh'l'd, and pso ri at ic IIllin vo lved c piderilli s 
w,,-' t·e a.-;scssc ci h y th e ulli va ri ate o ll e-way analysis of v ariall ce test. 
IlESULTS 
S6 Kinase Activity Is Increased in Psoriatic Lesions We 
l11easu re d 56 k in ase activ i ty in n o rm a l. psoriatic unin volvcd (nor-
mal-appea rin g), an d psoriati c in v o lved e piderm is. S6 kinase " c tiviry 
in psoriatic in vo lvcd e pidermis was elevated 3.7-fo ld (p < O.O() 2 , 
n = 6) . co m pa re d to unin volve d e pi de rmi s. a nd 4 .7-fold (p < 
0.00 I . n = 6). co mpared 1'0 normal epid e rm is (Fig 1). There was 11 0 
signifi c a n t differe n ce in 56 kinase ac tiv ity between n o rmal and 
p so riari c unin vo lved e pidermis. 
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Figure 2. S6 kinase mRNA and protein I .. vels are not in creased in 
pso ria tic lesions. (.'1) T() r~1 Il..NA (40 /J.g per lall e) li'orll k e r~t lJ rl1 e hiopsies 
w;" hybridized wi tlr 1''' P[eDN A prohes spe['ili c fo r 1>(, ki na se alld th e 
('o lll'r tl i gelle 36 B4 . Hyhridi zation signa ls were Cju;nttified hy 1'1 IOS-
ph tl rlnt ~ger , anti v:dll es for S6 kinase we re lI o!'!llalizeci to v~ l u e, for 36134. 
1);1 1';1 we re sca led h y cli v idill g h y t h e I1Il:an of tli e Il o rllwl g ro u p. T h e re fo re . 
hal' hei )!, llts rep rese lll fo ld iller,,;tse of SG kinase 11lRNA lev,1 relative to 
1I 0!'!nal epide!'!ni s. ( Ii) So lu"l" proteills fro lll kl' rato ille biopsies (40 p.g 
pro rc in per lane) we re a1la lyzed by w L'<\ lcrll hlut. MClllhrall cs we re ill cu -
b:tI·ccl with speeil'ic :tlltibody to S(, ki n:t se :tlld illlllltllt nrertctivc b:tllds 
vil\lIn ii7cd h y l' llh:lIl Cc d c il c lnillllnilll' !Wl' Il Cc. Ibnd dell s it ies o f 6 kin ase 
protei n were quantifi ed by ia'\c r dC Il "itornc rry, Data arc 11I e :lIl S :t 5EM 
o h t:1 ill l'd fro ll1 fI ve (unillvol ved ) or s ix ( 11 0 1'111 ;) 1 a l1 d ill vo lved) subjec rs. 
Nonn. nn nna l; Il1 v. ill voh'l'd; Ull in v. lIlIin vo l ved, S(. ki nasl' i ll1lll1l1l0p re-
c ip ir:u cs fro l11 n OrJll :d . ill vo lved. ::Jlld ullin vo lved cpidenlli'\ Were n.: so ln :d by 
H' Y;, "od il'llll dodccyl s llil'~It'c- pol yac ry l ;l1nid c gel e lec tro pho res is and v isu a lo-
ized b y sil ve r l'taill. 
S6 Kinase mRNA and Protein Levels Are Not E levated in 
Psoriatic Les.ions In creased 56 k inase activity in pso ria tic le -
sio ns, described ahove, co ukl occ ur as a res ult o f in c re'lsed S6 
kinase ex press io n and lo r activation of pre-ex istin g 5(, kina se. To 
address thi s iss ue, we detc rmined 56 k in ase t11l tNA and prote in 
leve ls in no rmal and psoriatic e pide rmi s. North e rn anal ys is of tota l 
mRNA fro m norma l, pso ri atic unin vo lve d , and psori atic in volved 
epid e rllti s usin g a full -le ngth hulltan 56 kinase c DNA pro be yie lded 
a sin g le tra nscript of 2.3 kb (Fig 2a) . R.e lativc 5 6 ki na se mKNA 
leve ls were silltil ar in n o rmal , tlnin vo lved. and in vo lved pso riati c 
e piderm is (F ig 2a). 
\J(!e nex t detel'lllincd re lati ve SC, ki nasc prote in leve ls in n o rmal. 
psoria tic in volve d, and pso riati c ttllin vo lved ep ide rm is b y iml11uno-
blot analys is. We found, sim ilar to S6 kinase m itNA levels, no 
dillc )'cnces in 56 kinase prote in le ve ls am o ng normal , unin vo lved, 
and in vo lved e pid e rmi s (Fig 2/,) . T his resul t was co n fi rm ed b y 
di rect m easurement of S6 kin~ se prote in , v isua li zed by sil ve r stain, 
ill imm ull op recip itates. 56 ki ll ase protein levc ls d id not dine r 
among no rmal. ttnin vo lved, and in vo lved ep ide rmi s (Fi g 2/,) . 
Taken togethe ,·, the above dal'a demonstrate that in creased S6 
k in ase activity in psori :ttic in vo lve d epidermis is du e to activatio n of 
pre-ex istin g 56 kin~ se , ra the r than in creased 56 k in ase express io n . 
TGF-ex and EGF Stimula te S 6 Kinase Activity in Human 
Keratinocytes 5(, k ina se is activated in response 1'0 binding of 
extrat"e llul ar m ed i;n ors to the ir cogn;lI e cell Sttrf: lce recepto rs. To 
gain in sight in to m ech anism s of SCi kina se ac ti vation , we exa min ed 
rh e abi lity o r seve ra l m ediators, kn ow n 10 be prese n t in psoriati c 
le sio ns, to activate SC, kinase act ivity in culrured IHttn an keratino-
cyres. Ex posure of kerar in ocYl 's 1'0 TGF-cr o r EGF in c reased 56 
ki n ase ac tiv ity approx ima te ly :I-fold (Fig 3a) . Under the sam e 
co nditi o ns, TNF-cr, I L-I a, I FN-y, an d TGF-{3 1 f:li lcd to stimulate 
56 ki nase acriv iry (Fig 3(/) . Unth ECF and TGF-cr b ind 1'0 the EGF 
rece J1(·Or. T hi s bindin g activa tes th e EGF receprnr inrrilt sic tyros in . 
kina se, \V hi 'h is req ttired to tran sdu ce signal s that lead to ce llular 
responses. T he re fore , we next exa mined w hethe r TGF-cr stimula-
rio n of 56 kina se acri v ity was dependen t o n activatio n of EGF 
recepror inlTinsic.: tyros in e kina se activ ity. TGF-tv-s timulated S6 
k in ase ac ti vity was inhibitcd in a co ncentra tio n- d epende nt m an nc r 
b y 1'1 ) I 53 () Yi, a spec ific inhibito r o f EGF-recepto r ty ros in e k in ase 
(Fry 1'/ nl. 1')94) (F ig 3/,) . T hese da ta suggest that stimu lation of 56 
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Figure 3. TGF- £, and EGF ac tivate S6 kinase in cultured human 
keratinocytes through the EGF receptor, (.<1) Human kcr;ttinoc),tes 
we r" in cuha t"d for 20 min al .'n oc with III 11 1; TGF-t, per m!. EGF, TNF-cr. 
IL-1 n, IFN-n, or TGF-{3 1 T(;F-u or EG F "ers ll s conrro!' I' < II .OS: 
StiIlHiI :Il' jOll o r S(I k inase act iy ir y by othe r :tgoni s l" s w as Il o l stati sti ca ll y 
si~llifi c:lIlt , 56 ki lla se acti"ity was Illeas lI red as described ill lH tlt cI';n!s dlul 
11".,It"ds . Data are e"pressed:ts fo ld in crease nfS(, killase acti viry rel ative to 
unstimulated controls. (13) EGF rL'ceptor t')Tos itlc kin:t sL' initihit or I'D 153025 
reo u ces TGF-O'-srilllulatcd S6 kinase a c ti v ity ill hurllall kcrat illocytcs. 
Kcratin ncyrc:s wet'e ill cuh:ttcd with tit e indi cated concelttTa tiom of I' D 
153035 fo r III min pri nt' to addiriotl of T GF-cy ( II) ti l; per nd). Dat:t :tre 
1I1 C;J n S _ SEM of three l)r ({) ur csperilll e ill s PCril) rllH.·d in dup licate. 
k inase b y TGF-a is dependenr o n acrivatio n of the EGF receptor 
tyros in e kina se in human keratin oc), tes. 
Rapamycin Inhibits TGF-a Stimulation 0[S6 Kinase Activ-
ity in Human Keratinocytes TGF-ex is synthesized b y human 
ke ratin oc),tes and acts as an autocrine mitoge n. In T ce ll s, 56 kinase 
is activated by the autocrin e mitoge n I L-2, and thi s stimul ation is 
inhibi ted by rhc imntun os upprcssa llt rapatl1 yc in (Schrei e r Cf nl. 
1993). W e examined , th e refore, whethe r srimulati o n of 5(, kin ase 
activity by TGF-c., in cultured hum an ke ratinocvtes , co uld be 
inhibitcd by rapam ycin . TGF-rv stimulated 56 kinase activity nca rly 
3-1'Old, and rhi s stimul:t t io n wa s inhibi ted 84'1., by 0 .2 ng rapam )'cin 
per 1111 (F ig 4). Addi tion of hi ghe r co nce l1 tratio l1 s o f rapatu yc in 
(2-2 11 I1 g per n1l) comple te ly inhibited TGF- cr-s timll latcd and 
substantiall y inh ib ited hasal S(, kina sc activ it ), (Fig 4). 
Rapamycinlnhibits Human Keratinocyte Growth We n ext 
ex amined w hethe r rapam yc in , at concentrati o ns that inhihit 56 
kinase activ ity, inhibits ke ratin ocyte g row th . Rapam )'c in was added 
to subcontlu e l1 t cultures of ke ratil1 0cytes in complete M C D13 153. 
Rapam yc il1 inhibited ke ra t il1 0cyte g rowth in a concentration-
depend ent J1t al1tll!r betwee n O.02-2() ng pe r III I (Fi g 5) . Fifty 
percent g rOW l h inhibiti o n wa s o bserv ed at 0. 2 ng pe r ml , whil e 
co mplete g rowth inhibi tion occ urred at 2() I1 g pe r Ill!. T hese data 
3.5 
3.0 
>-~- 2.5 > Q) 
:;::~ .:i~ 2.0 
Q) 0 
<II C 
",- 1.5 c'O 
i:o 
U. 1.0 tD ~ 
en 
0.5 
0 .0 RAP 0.2 (ng/ml) 
TGF-CI + + + + 
Figure 4, Rapam ycin inhibi ts ac tivation of S6 kinase b y TGF-£r in 
c ultured hUI11an kcratinocytcs. Non l l:d Illlll1 :l 1l kc r;H.ill oc)'tes wcre 
trca ted for I I) Illin a t 37°C w ith th e illdi c;ltcd CO II CC lltratioll s nfrap:lI11 yc in. 
prior to "dd ition of TGF-II ( I f) 11g' p CI' 1111 ) lo r 20 Illin at .n°c. sr, kil1ase 
ac ti v it"), \,v as l1leasured as desc r ihed ill 1\1n/C'rio/s fl lld '\let/ lO cI .... na ta nfC 
111 Ca ll S :!: SEM of thn.:c cx p c rillll': l1ts, RA P, rapill1l ycin . 
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Figure 5 . Rapamycill inhibits growth of hum a n kcratinocytcs . 
Normal hU111all kerarill oc)' tes (5 X 1 U" per ",e ll ). ill 96- we ll p lates . we re 
trea ted \v ith ('h e il1dicated CO Tl l"t.! lllra t io Il S o f r ;qJ"I1Il ),cin o r n. I IXI c tlwllo l 
(ve hicl e cO ll t rol ) ror 5-7 d . Ce ll ~rowlh was assessed hy Il eurral red d ye 
b indin g assay . Data :IIT cx pn:ss~d as pe rcen tage or ve hicJe-fn.:;Hed c lll rurcs 
defi ll ed as 1 (H I'X,. Data arc Ill eallS :': SEM o f Ie)! I I' ex pe rim enrs. 
ind icate th at rapall1yc in illhibits keratin ocyte growth ill a CO ll cell-
t ratio n-depe nd en t f~l s hion :lll d thar thi s inhibiti o n occ urs at conCell -
t rati o ns simi lar to th ose thar inhi bir S6 kin ase activatio n . 
D ISCUSSION 
Q UI' results indi ca te that increased S6 kinase activ ity in psori atic 
in vo lved epid ermi s is du e ro post- tran slatio na l act ivatio n o f S6 
k in ase, pres umabl y thro ugh pllOsph Ol'ylat io l1. O ur data arc consis-
ten t w ith pre vio us o bse rvatio ns dem o nstrati n g that S6 ki nase 
act iv ity in quiescent Swiss m o llse 3T3 ce ll s is markedl y enhan ced in 
resp onse to mitoge ni c srilllul atio n and that thi s in creased activ ity is 
associated wirh phosph o rylatio n of S6 kin ase at mu ltipl e se rin e / 
th reonin e res idu es (l3 all o u ('( a/. 1988; Fe rrari and T ho ln as, 1994). 
TGF- Q' is stru c tura ll y re lared to EGF and bin ds to the EG F 
recep to r with hi gh atfiniry (Schreibe r 1'( a/. '1986). T GF-Q' is 
m irogenic for cu ltured n o rl11a l huma n kera tin ocytes (Kru eger ('I a/. 
1990), an d pso ri ati c kcr:ltinocy tes (O I:1nir<l1l <'I (/ /. 1995) and ha s 
more p o te n t an giogenic :lL" tiv ity than EGF ;11 tJ;tJo (Schreibe r ('I n/ , 
1986) . Ex press io n o f T GF-Q' mRNA and prote in are in creased in 
pso ri atic in vo lved ep idermi s (Elder 1' ( a/, 1(119) . and EG I: recep to rs 
a re in creased in a ll v iab le la ye rs o f psoria tic invo lved epidermi s. 
especia ll y in the upper spin o us layers, as co mp:lred with n o rll1 al 
e pid e rmi s (Anwgi el a/. 1988; Kin g 1'1 11 / , 1 ')90; N:1ll1l ey <'I (/ / . '1(116). 
T hu s, resu lts indi ca te tha t TGF-u is an end ogen n us ep ide rm al 
li ga nd fo r EGF recep to rs (Elder ('I a/. 1990a). and activatio n of EGF 
receptor pro tein ty ros in e kinase hy TGF-Q' ma y play an imp o rtant 
ro le in the pathogenesis ,.) 1' psoriati c epiderm al h ype rpla sia (Elde r /'1 
ai, 1989; Elde r 1'1 a/. 199 0a). 
130th EG F and TGF-(~ st imula ted S6 kina se activi ty ill cu ltured 
huma n ke ratin ocytes . but m he r cyto kin es . in cluding TNF- cy. IL-
l a, I FN-),. and TGF-':l'1, !t ad li ttle o r n o eltecl. Fu rthe rm o re, 
stim ulati o n of S6 kinase acti vity b y TGF- ct was inhibited hy 
rapa ln ycin , in a concentra tio n- de pe ndent f;lshi o n . Inh ib itio n of 
G l-to-S phase ce ll -cycle progress io n b y rapalll yc in is associa ted 
w ith inhibi tio n of ph osp ho ryl:ltio n and activ:ltio n of S6 kill ;]Se 
(C hun g /'1 (/ / , 1992; Pri ce el a/. 1992). Consistent w ith these 
o bservatio ns, we fou n d th at rapam ycin inhibited growth of cultured 
hum an keratinocytcs. It is lik ely tha t rapam ycin inhibirs ke ratino-
cyte proliferation by bl ock in g S6 kin ase activity . In hibiti o n of 
kera tinocyte growth by rap<l lll ),c in has prev io usly been repo rted 
(D un ca n , '1994) ; however, ar least 1 U-fo ld hi gher concen trations of 
rapa 1l1 )'c in Were uti lized thall We fo und to be necessa ry to inhi bit 
kera tinocyre growth . In rhesc studies. n eithe r regul atio n o f S(, 
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kina se ;Ictivi ry by agoni srs nor its inhibi (ion by rapam)'cin was 
exa min ed . 
Rapam ycin-FK13P selectively bl ocks acti" ati on of S6 kin ase . 
activati o n of mitoge n-activated prote in kina ses is not inhib ited. 
Furtherm o re . rapa m ycin- I: lilll' docs not appear to inhibit S6 kinase 
d irec tl y. Instea d . rapam ycin-FK BP intL'racts with mamma li an pro-
te ins desig na ted RAFT (rapa m ),cin and FKl3P I2 targets) or F I~A P 
(FlillP-rapam ycin-assoc iated prore in), wh ic lt show strik.ing h o m o l-
ogies to th e yeas r TOR (ra rger of rap:lm ycin) gene prodll cts 
(He.i nnan e( ,d, I ~') I ; l3 rown ('( (//, 1 9~ -I ; Sa batini /'1 a/. 191)-1), 
R ecent ev id en ce indi cates that FRAP/ RAFT Ita s a rapamycin-
sensiti" e S(, ki na se kinase activ iry. w hich is necessa ry for S6 k.in ase 
ac ti va ti o n (l3rown ('( (/ /. 19<)5). 
O llr tind in gs. which dem o nstra te that S(, kin ase ac tl\'l(y is 
in creased in psoriatic invo lved epiderllli s and that rapam ycin inlt ib-
its both S() ki nase aniviry an d keratinocytc pro life rati o n. suggest 
that in crease d S6 k in ase activity in pso ria tic lesio n al epidermis Ill ay 
play an impon:an t ro le in the pathogenesis of psoria ti c epid erIll a l 
hyperpla sia. 
" '(' lI 'Illlld Ii/(t' (t' n(~· /lt ) I /1II'(~i.!.(' SIII /.\! ) ' j (II,d Kris ti" ,-, BlIrr lill" Il'r /lII;rlll assiSrrll1(C, 
T f't! H al1lilt o/J .fill' sfllf isr;r fll mUl/),.";s, alld C /fllldi., I-liJl .lll ,- pl"l'jltlrari'lll t~" 1111'S 
IIlflIIIISO-illl. 
R£FER.EN C ES 
A ll wg-i M . O i! ilW;I S. Ucda M. Ni$h ika w:l T. A bl.' O . Shillli711 N: /)isrrihutioll n f EG F 
rCCl' p to r l.'x prc :->s ili l-! :lIld I )N A n..:pl icarillg e pid ermal ce lls ill " su ria .... i :-- \'Ul g:1T-is alld 
B O\\'l' II '~ d i :-.ca ~ I..'. Hr 11)1'1'11/ 1""/ I I I) : fl() 1-- 6M{. I YHH 
Bahidl I-I. B orl' l1 f-j -l' lIlld H-: SII"t] ( lllrl'-:leti"ity rci;nil)lI !< ldp (SA R ) III o del :;: l'~ l a hli ~ l\l,;d ;/1 
" jnv w irh rh e Il c utr,ll red (,Y I<Ho x: il-it-y ; \ I\ ... 01 Y_ T I1xicl'/tl.I! ),;1I 1-;/'-0 I :J-I) . 11) :-: 7 
l3a ll o ll LM. Luther H . ThuIII:t\ . (; : M A I'2 kin;\sc a nd 701, Sfl ki ll :l )'l' lil' ll ll di ... tilln 
s i g n;lllill ~ pathway s_ .\ '/1"" '1' _' · I I) :J .. H~-3 ·P). 11) 1) 1 
Ball o u LM. SiC~lIla llll 1\1\ . T h tl lll:ls (; : sri ki na).c ill ljUiCH-l' lI l S \\ i).). Il UHI ).C J T J n · l\,. i). 
act i\':u c d ilY plHh l'horyl:ll iplI ill IT :' I Hlil " ~' 10 :-.c r\llll IrC:I !llIL' Il t. ! )"t1r' 1\,'111/ .-Icad Sd 
U S.·I HS:7 I ,'4 - 71 SK. I ') ~H 
Ik ire r BE. M ;lIt ila PS. S(:ll1d;lCJ'l RF, I krzl' llhcrg LA. BlIraknfr SJ- C arh, rl'l' G. 
Sc ilrci lll'r SL: T wo di"tinct :\ i)!lliIl t r=ll1 :.ltJi s s-i~H1 pa th w :l Y:' ill T IYlIll'lwcyrl' s li n ' 
illhihitl~ d hy 1'00 Il p l l! X l~S Il ll"lllL'd hL' \wCCII :III il1l1llulltlphilin and e idh:r r:K ~ II () or 
r:lp:lIll ycill _ p/'(l( -, .... ,1t/lf ... Irlld Sti l 'S.-1 ~7 : 92.3 1 -9 2.v:; . 19 1)0 
Hro w ll EJ , Albl'rs M\V'. Shill TH. Ichikawa 1<, Ke it h CT. La ll e \XlS . Sch re ihe r S l : A 
m ,lIl ll11;t1i all protc in t;l rg"CICd hy (; I- ar rc-.:t illg r:lp :l lll ),cin - rcl-qHn r c01ll pl e x . .\"11 -
"'n' 2.V):7;; (1 -75S_ 11)9 .. 1 
UnH\' 1I EJ. llL-a l PA. Keit h C T. C l1l'l1 .J . Shill T IL Sl'ilre ih l' r SL: COlli 1'0 1 0 1' p7 t1 S(, 
kil1ase In' kinase :Ic!"i\' it" o ( Flt A P ill I'il'o . • , ·fif 'IIO· :. 7 7 : ~-I' - -1-16. I I) <) S 
C: 1HIIl I! .II<. I(' II L) C.J. It c6. Bkll i;, J: I ta p :lIll Y~ ' iJ1 - H,-BP spc(- ia l1 y hl ll l-k!\ gro w d l_ 
dcpc llllc n r ;lc ti" ;lril)l l o J- an d sigllal in g ,,~ . dll' 70kd S (, pro tei n ki ll a ::- c _ CI'II 
(II) : 1227- 123(,. 1')1) 2 
Conk P. Pinl· lkow M _ KL' L·h ll· \ '(t . (; ran~$- nl'al It. C (lll;":~ n . .J . Shipk y G : Al1IphirL' !o! u lill 
lIleSSe ll )!;n R.NA i!\ d l" ' <1tl'ti ill Il\o ri alic L'pidl' r1ni s ;l ll d g;l!\ troinn .. \ ,i ll al l'Ilrc ill P-
111 ::t ~ _ (.';/1/( ('1' He's S:!: _l 22 -1 -Yl2.7 . 11)92 
I hI \\' II \\':1 11 d J: Iteglll;lIi ll g: S6 ki n:l ;\ ... . Xi/WI'!' 3 7 1 :_\ 7H-37tJ . 11)1) -1 
\)UI1IOI1I FI. -S taru ch M..J . Koprak SL. rvl c1i lh l Mit. Sil!.:ll N Il: Dbl inn I1\ l'l' h ~lI1i!\II1 '" or 
mp p;'l'ssio n ot' 1I111 rill 1' T n~ l1 acri":lI i(l 1l hy (hl.· rl' la tl'd 111:1c rol id L's FI": -~ 0 6 ,1Ild 
rap;IIJ1 Yl' ill _ J 1111/11/11/01 1 .. 1-1 :2.S 1-2SH. I I) I){I 
1 )UII C 111 II : i)i llcrc m i:lI in hihitioll (If Oll ;\Ill'lHI' T - ,-c lJ - l11 cdi :lI l'd I'L' ,lnillll\ alld L-pidl'l"-
111;1-1 n. 1l prolif"c ra tinn h y l-yL"il.l !o po rill A. FI{ S(J (l _ ami r:1p:l11l~ l-in . ) / 1I1 ' 1 ·.~ 1 /)1'/'111,,,., 1 
11l2:S-l - XX . IIII}-I 
Elder IT. I:ishe l' (;J. 1 indql1i ). t PH, BL'11I1ctl (;L. Pill'clk o \\' Mit. Co ffey .I r n.J _ 
[~ll i l1 ~ s \\' ort h L. J) t.:rYllc k rl. Vonr!ll'l' s JJ : ( h ' I.:.' r l· s prl'" inn nr rr.'l1 .\Ii.lrl11ill ~ g rowt h 
r;1C t n~- n' in p \ n rial ic cpidl' nlli s_ ..... -( ;/ ·// 0 · 2 -1.1 : ~ I 1- X I ~I. II) H9 
Eld c r IT. ({kin SU. T;\ \' akktl l f\_ Fi ~h l.:r C:,1 . N il·k"l o lfU.I. Vnnrh cL·:-. JI : C; r(~'\' lh fa c lur 
;, lI d prolO-nll coj.!'l·lIl' csprc)'o!o illll in p~oria \ i s. -' h'l '/'S' Ik1'l1/11I1'/ 9:'):7S- I)S. 11)1) l)a 
Eld l' l-J T, Ta\' :lkkpj A. I{ k il1 S U. Z,cigl,.' r M r:: . \ '\I iL·It :! J\ 1. V t)()I-hL·l: ... .IJ: Pr\1 10(l IlCllgL'IIL' 
expression ill lIo l' m :li ;1I1d I' ). o ri a ri c ... k ill . -' 1111 '1',,-, /) t'I'II' lItcl/ l)4 : I K- 2.:i . I t) C)() h 
Fl' na ri S. I'c :l rso ll RH , Siq!; lIl :l lltl M. 1{0 2111:1 SC . Thlll11:1 .... C : Thl~ i I11 I11l1l10 ~ lIpprl' )'o ... al1l 
r:l Jl:1l11 yc in illdll/"C!i ill;!ni\'ari (lll l ~'- 1'71)",'10 '" dIn lugh dL'l'hn"phnrylarinn oj" a l1 {)\' l ' l 
M.t o f sitl!s_ I Hillf (:111'111 :! (I X: I (,ti9 1- 1 h ll')-I, 11) 1) _, 
Fl' IT ; II~ i S. T hUll);;" G: S(' p hospll<lrylal itl tJ ;1l1 d tilt.: p70S (JI{ /p~S S (, J{ . C ril U t'I' Hil'c"//('I// 
,\leI/ l1il1 / ] /) ; '\K:1 - .. II ,L 11)1)-1 
Fishe r G.I. ES 11l.1111l.l . G rilli d l\ e EIV\. 1" . .11 \\';11- li S. 1 hl e ll EA. I -L1I111lI Crhl'r~ C. Eld e r .IT . 
J{ ar;lhin G/). N iLkL' lu ll" UJ. Cnnpn J{ Do. VOlH· h ~ ~ · .... .1./ : Ce ll ular. illlillull o in gi c and 
hi ochc tlli c;i1 dlaractl, .. i/;lI·itlll (II" l11 pi c al rl'rill(lil- .1 t.: id- rn·at ed Illlln :11l "kin . ,11I1't':N 
1)/ ·nll.,ltJl t) f, :ClX H - 707. 1')91 -
Fry I). Kr;lker A. IVkMit'lIl' ;ll A. A lllhnl)'oo L. NL'b ~ Hl J. I l' n l'~lld \V. COllllUr:!o It. 
B\'id !!:c~ ;\: A SPl'l-ili c inhihi l lir Cl ( dl l..' i..: pid c l'1 11;) I ~nl\\· th (;" -10 1" recq )tol' t ~Tll .. iI1 L· 
kinase . .)r i('ll(t' 2()~: I UIL\- l n95 . 1')1) .. 1 
H ci lll1 ;! 11 I. M~)\' , ' a N it. 11:111 rVIN : J'arg-~·t'i Ii. )!" n· 1l c ye ll' :IITC ... t by th e illl ll1 llJl n~ lIl'­
I' rl' !\~;lIl1 r;ll' ;lIll yc ill ill Yl':lSI. -"0'1'1 /(, ' 2 ~d : /) {\ ~-l) fll). 1(1) 1 
10 2 C H <l 1 fiT / IL 
King .J f LE. G~\l l:S R E. SlCsciJ cL" k eM. N alln ey L1 \: T he EG F/ TGFo' recepto r ill "kill . 
J /lI/ IC'S1 /) /,,., I/ f/(,I/ 1) 4 : I (14 S- 170S. 11)l) () 
I<rllcgc r.J G . K rall c .J F. C ar te r I) M. GO ll lic h AU : R o le o ( gn)\v lh (i-Ie mrs. cY lok in L' s. and 
thdr recc p ll) r~ ill t he path o genesis of psoriasis. -' /11,1(,.\', J)rnllalo/ f) ·I : I :' SS- I-IfJS. 
I Y911 
Lac l11l1ll i U K: C lca va!;c of Mn rn uf,ll prot l.: in s d uring the assembl y o f the hLond 
hac lc rio ph:lg l.! T il . {\lfl /II f1 ' 227: (, 811- 6XS. I (nO 
i..;IIlC !-I A. Fernand ez A. L:lI ll b NJ C . T hOllla s C : p 7 0 Sf", fU I1 Cl io ll is cssl' llli :i1 Ii:lf G t 
prog ressio n. Nil / li ft' .1 (,3 : 170 - 172. 11)1)] 
Mi ll ~ XF. Burg-c rin g HM T . \Xlt, I 11 1 Slrtl l11 S. C l:tcsson- W clsil L. Hddill C H . n os .J L. 
KOZ III :! SC. Th o mas G: J\c li v:II' ill l1 or p7(J / pX5 SCI kin ase hy ;1 pa th w;lY illd c p c lI -
n e ll!' ofp2 J ~" ~ . ;'VnJllfI' :\7 1;.J2 (1 --12 ') . I {)9-1 
N anl1 l' Y LB. Slo,c l1 cck e M , M ag id M. I<i n p; LE .II': Alrc n.:d 11:!5 1l e pidc rl1la l g nl\v th 
(;U: lor hi nd in g :md rcn.: p tt) r d islri hu t io IJ in pSl )ri asis . .I ll1 l'l'sr Dt'rJll tliol ::-; (,:2 6() -2 (, :l . 
I fJ H6 
Ol nn inHl AI<. H;lkc l' BS. G arill ch JJ. Pow lcs AV, Fry L: A l"(lIllp;lri so ll or t hc 
Sf jlliulacory clf~c[s of cywk jll c ~ 0 11 lIo rn ", ) :l IId IH'oriar.ic h : ral"illo(.:ylcs t',1 lIil l"ll . . -i l"t'll 
iJel"ll/ tl'(I/ U/ 'S 2H 7:23 1-2:\ (1. 11)95 
Pir·tdko w MR. Sc orr RE: N ew tccillliqll l.'S Ii") !" lh e ;11 "itrel c ulrurc or Illiln an sk in 
kc rat ill o cytcs and pe rspectives Oil rhe ir II Sl' I(lI' ATal'l in g o r p;lli l' J1l"s w ith e xt e nsivl' 
h ll l'll s. t\ltI )lfI (.'Iill Pro( (1 1:77 1-777 . I I) H(, 
Price 1.), ';rove ". C:ll v() V . Avnll..:h.J. Bie re r BE: R apalll yc in- ;nduccd inh ibi tio n o flh c 
70- ki lodal LO Il S6 p rote in kin ase. Stii'l/("t' 257: 973-977. 11)92 
Q u c .\ lIi :llI x vr~ : 111 1 "' 1I110.Wl'prCS.'i;'IJI' .~ : I DOls /0 ill ves rig ;lI c fh e p l1 y~inklg i (' :l 1 ro le of 
("y t oki n c~. Hi(I /£$sa)'J I S:73 1-75H. 11)9.1 
T H E JOU RNAL 0 1' INV EST IC AT I VE I)ER M AT O LOGY 
lt cyno\ch N . Ui1 l da s'i a n,,~ J. I lc lld ~rso ll P, Sh u le r .1 . Hall as L. I3l1rn $ I) . Moolllaw C. 
r:b h e r G : Tral1'IOCilli o ll a nd dow n rc!;! ul ar io ll 0 1' pro l rJ ill k in asl-' c: i SUt' ll z y lll \!~ ­
a lp ha and epsilo n h ~ ' p lhH'b(J ll's ler and hrymanri ll- I ill JHlIll ,lI l k{' ra { il l(l ~y ( e S and 
fihro hla sts. j " "'f." 1)('1'11111/(11 I 03:3 (1--t -.1 (, ') . 11) l)-J 
S:lh:ltin i DM . Ert'ljrml rlc_,t'- lk o lll:lgt' n . LII; M . T elllpsl P. Sn yd er S H : R f\ PTI : iI 
lJlol lll ll t:l ii a ll prote in Iha t h inds w FKB I' 12 in a rapalll yc in -dl' pc lldc lI l (;Ishi oll :lJ1d 
is ho mo logo lls tn Yi.·ast T O R !\. Cd l 7H :35- 4"' . 11)1) .j 
Schre ibe r All. \V ill k ler M E. IJ i."·ynck It : Tr;lI l.~ I ( )J"I l1 ill g g row lh I':tc lo r- cr: a tl w re po rCTll 
;\ll ~ i f.lbC lli t.: tlh.:d iator th all e pid c I'Ill a l g row th f;lcror " S n 'CII( (' 2.12: 1 2S 0 - 1 25~ . 1986 
Scim . .' il.' r M H . Bau lll ann C;. ZCl1kl~ G: Inhih it ion o f T -ce ll s i g tl a l i lt ~ path ways hy 
il\\l\HI1\Op hilin d ru g Cl\l\l l' lexes: ~\ rc "idc cH~t:t, in herc tl t ttl imI\\UllOSlIpp rt.:sSl\,l...' 
p ropl' rri L:s? 'tfrll is/Jiml' !'nJl' 2.1:5 02-S () 7. 1 ?'JJ 
S L hri e hl.~ r S: ' n\l l\\l t\ () phiH i ll -S I.· n siti\T ~ prole in phnsph~t;\ s l.' anion ill n' ll :. ignal1 ng 
pa d l\v;l)'s. Cd) 7 tJ :.1 (,S-J M( 11)')_ 
Shipley c n . Pittclkow Mrt..: C Olll rn l of grow th :md dill"l'l"cm; ;n ioll ill P ill"tl o f human 
kcra till o cYl CS cultu red ill scrll lll - (i'l'C 1I1 Cd iul11 . ,-11'1'/, /)CTIIIII ((I I 123: I :) ·1 / :1- 154 4:1. 
I ')~7 
SCcwarl MJ . T llOl1ta !i C : M irogcll csis and prntL' in ~y lHh c'i i s: ~I ro Ii.· fo r rihosO I11 ;,1 1 pro re in 
sr, phosph orylation . HiIIEss(/) 's I (d~ n9 -R 1 S, 191') ·, 
T erada N. Fran k lin itA. Lu cas J.J . Ul i.:lli s J . Gdl:l ml E\V: Fa iluri.·u frapam ytill to bl ock 
proli /c r<l ri<J 1/ o ll ce re ~ ring ce ll .'\" ha \'c c Ill l' r i.:d III l' (L' ll cydi.' dL' .~ p i lt.· illa cl'i val io n of 
p7U SG kill ase. ) Hi,,/ O WII I 2 6 ~: 1 2 1162- 1 2 11 (, H . 1'1'1., 
T ho m so!l A W . Starz l T E: N l''' '' iIllIl1l1l1 0 s llpprc~!' i\ ' c drugs: m echanist ic ill$igi1 rs an d 
pO le llti a l tlh.! rapc ll ric .. O V;I1t ( CS. IJI/ !/ II llIol N.n' I J (,: 7 1- ')H. 1993 
